Three drugmakers settle with California over deals to keep generic medications off the market

Teva maintained a monopoly over sales of a narcolepsy drug by entering “pay-for-delay” deals to delay a generic version for six years, Atty. Gen. Xavier Becerra’s office said.

from California https://www.latimes.com/business/story/2019-07-29/drugmakers-settle-california-pay-for-delay-lawsuits
via IFTTT